Expression of transforming K-Ras oncogene affects mitochondrial function and morphology in mouse fibroblasts.
暂无分享,去创建一个
Lilia Alberghina | Marco Vanoni | Ferdinando Chiaradonna | Daniela Gaglio | L. Alberghina | F. Chiaradonna | M. Vanoni | D. Gaglio
[1] Steven P Gygi,et al. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. , 2005, Nature.
[2] Eyal Gottlieb,et al. Mitochondrial tumour suppressors: a genetic and biochemical update , 2005, Nature Reviews Cancer.
[3] M. Brand,et al. Physiological functions of the mitochondrial uncoupling proteins UCP2 and UCP3. , 2005, Cell metabolism.
[4] J. Gamble,et al. An oncogenic role of sphingosine kinase , 2000, Current Biology.
[5] Yan Shi,et al. Rapamycin inhibits Akt-mediated oncogenic transformation and tumor growth. , 2004, Anticancer research.
[6] F. Villarroya,et al. Overexpression of UCP3 in cultured human muscle lowers mitochondrial membrane potential, raises ATP/ADP ratio, and favors fatty acid versus glucose oxidation , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[7] S. Schreiber,et al. Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[8] L. Tacchini,et al. Hepatocyte growth factor signaling regulates transactivation of genes belonging to the plasminogen activation system via hypoxia inducible factor-1. , 2003, Experimental cell research.
[9] L. Ridnour,et al. Glucose Deprivation‐Induced Oxidative Stress in Human Tumor Cells: A Fundamental Defect in Metabolism? , 2000, Annals of the New York Academy of Sciences.
[10] P. Vandenabeele,et al. The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet , 2002, Cell Death and Differentiation.
[11] Marta Martínez,et al. Alteration of the bioenergetic phenotype of mitochondria is a hallmark of breast, gastric, lung and oesophageal cancer. , 2004, The Biochemical journal.
[12] T. E. Fitzpatrick,et al. Hypoxia stimulates urokinase receptor expression through a heme protein-dependent pathway. , 1998, Blood.
[13] R. Benz,et al. Regulation of glycolysis by Raf protein serine/threonine kinases. , 2002, Advances in enzyme regulation.
[14] K. Chayama,et al. Expression of hypoxia-inducible factor-1alpha is associated with tumor vascularization in human colorectal carcinoma. , 2003, International journal of cancer.
[15] J R Griffiths,et al. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. , 2005, Human molecular genetics.
[16] David E. Misek,et al. The bioenergetic signature of lung adenocarcinomas is a molecular marker of cancer diagnosis and prognosis. , 2004, Carcinogenesis.
[17] R. Jensen,et al. Control of mitochondrial shape. , 2005, Current opinion in cell biology.
[18] E. Espinosa,et al. Breast carcinomas fulfill the Warburg hypothesis and provide metabolic markers of cancer prognosis. , 2005, Carcinogenesis.
[19] A. Harris,et al. Predominant role of hypoxia-inducible transcription factor (Hif)-1alpha versus Hif-2alpha in regulation of the transcriptional response to hypoxia. , 2003, Cancer research.
[20] M. Perucho,et al. Activation of a human c-K-ras oncogene. , 1984, Nucleic acids research.
[21] V. Kavsan,et al. Reduction of the transcription level of the mitochondrial genome in human glioblastoma. , 2005, Cancer letters.
[22] Teruhiko Yoshida,et al. Identification of genes showing differential expression in antisense K-ras-transduced pancreatic cancer cells with suppressed tumorigenicity. , 1999, Cancer research.
[23] Defeng Luo,et al. Plasmalemmal vacuolar-type H+-ATPase in cancer biology , 2007, Cell Biochemistry and Biophysics.
[24] H. Krebs,et al. Metabolism of renal tumors in situ and during ischemia. , 1970, Cancer research.
[25] Mingyao Liu,et al. A Rac/Cdc42-specific Exchange Factor, GEFT, Induces Cell Proliferation, Transformation, and Migration* , 2003, The Journal of Biological Chemistry.
[26] A. Khar,et al. Differential gene expression during apoptosis induced by a serum factor: Role of mitochondrial F0-F1 ATP synthase complex , 2005, Apoptosis.
[27] J. Auwerx,et al. PGC-1α Turbocharging mitochondria , 2004, Cell.
[28] D. Hardie,et al. Improved glucose homeostasis in mice overexpressing human UCP3: a role for AMP-kinase? , 2004, International Journal of Obesity.
[29] Roger Y. Tsien,et al. Changes in intramitochondrial and cytosolic pH: early events that modulate caspase activation during apoptosis , 2000, Nature Cell Biology.
[30] M. Brand,et al. Hydroxynonenal and uncoupling proteins: A model for protection against oxidative damage , 2005, BioFactors.
[31] A. Alavi,et al. Akt Stimulates Aerobic Glycolysis in Cancer Cells , 2004, Cancer Research.
[32] Byong Chul Yoo,et al. Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance. , 2004, Cancer research.
[33] P. Puigserver. Tissue-specific regulation of metabolic pathways through the transcriptional coactivator PGC1-alpha. , 2005, International journal of obesity.
[34] D. Green,et al. Apoptotic Pathways: Ten Minutes to Dead , 2005, Cell.
[35] Krebs Ha. The Pasteur effect and the relations between respiration and fermentation. , 1972 .
[36] Peng Huang,et al. Mitochondrial defects in cancer , 2002, Molecular Cancer.
[37] E. Campo,et al. Differential effects of X-ALK fusion proteins on proliferation, transformation, and invasion properties of NIH3T3 cells , 2004, Oncogene.
[38] K. Chayama,et al. Expression of hypoxia‐inducible factor‐1α is associated with tumor vascularization in human colorectal carcinoma , 2003 .
[39] D. Wallace. A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary Medicine , 2005, Annual review of genetics.
[40] M. Rigoulet,et al. Activation of Ras cascade increases the mitochondrial enzyme content of respiratory competent yeast. , 2002, Biochemical and biophysical research communications.
[41] O. Warburg. On the origin of cancer cells. , 1956, Science.
[42] J. Pedraz,et al. Hydrogen ion dynamics and the Na+/H+ exchanger in cancer angiogenesis and antiangiogenesis , 2003, British Journal of Cancer.
[43] Emanuel F Petricoin,et al. Mitochondrial proteome: Altered cytochrome c oxidase subunit levels in prostate cancer , 2003, Proteomics.
[44] A. Martinez-Mir,et al. Multiple cutaneous and uterine leiomyomata resulting from missense mutations in the fumarate hydratase gene , 2006, Clinical and experimental dermatology.
[45] Saroj P. Mathupala,et al. Glucose Catabolism in Cancer Cells , 1997, The Journal of Biological Chemistry.
[46] Bert Vogelstein,et al. Somatic mutations of the mitochondrial genome in human colorectal tumours , 1998, Nature Genetics.
[47] E. Newsholme,et al. Maximum activities of key enzymes of glycolysis, glutaminolysis, pentose phosphate pathway and tricarboxylic acid cycle in normal, neoplastic and suppressed cells. , 1990, The Biochemical journal.
[48] Kathryn A. O’Donnell,et al. Myc Stimulates Nuclearly Encoded Mitochondrial Genes and Mitochondrial Biogenesis , 2005, Molecular and Cellular Biology.
[49] Huasheng Lu,et al. Hypoxia-inducible Factor 1 Activation by Aerobic Glycolysis Implicates the Warburg Effect in Carcinogenesis* , 2002, The Journal of Biological Chemistry.
[50] M. Barbacid,et al. ras gene Amplification and malignant transformation , 1985, Molecular and cellular biology.
[51] Bruce J. Aronow,et al. Chromatin Immunoprecipitation Assays Footprints in Glycolytic Genes by Evaluation of Myc E-box Phylogenetic Supplemental Material , 2004 .
[52] M. Guppy,et al. The hypoxic core: a possible answer to the cancer paradox. , 2002, Biochemical and biophysical research communications.
[53] E. Petricoin,et al. Mitochondrial proteome: Cancer‐altered metabolism associated with cytochrome c oxidase subunit level variation , 2004, Proteomics.
[54] M. Brand,et al. The reactions catalysed by the mitochondrial uncoupling proteins UCP2 and UCP3. , 2005, Biochimica et biophysica acta.
[55] Marta Cascante,et al. K-ras codon-specific mutations produce distinctive metabolic phenotypes in NIH3T3 mice [corrected] fibroblasts. , 2005, Cancer research.
[56] E. Feldman,et al. Insulin-like growth factor-I regulates glucose-induced mitochondrial depolarization and apoptosis in human neuroblastoma , 2004, Cell Death and Differentiation.
[57] H. Green,et al. An assay for cellular transformation by SV40. , 1964, Virology.
[58] M. Lutter,et al. Biochemical pathways of caspase activation during apoptosis. , 1999, Annual review of cell and developmental biology.
[59] R. Scarpulla,et al. Nuclear control of respiratory gene expression in mammalian cells , 2006, Journal of cellular biochemistry.
[60] J. Modica-Napolitano,et al. Mitochondrial dysfunction in cancer. , 2004, Mitochondrion.
[61] Marta Cascante,et al. K-ras Codon-Specific Mutations Produce Distinctive Metabolic Phenotypes in Human Fibroblasts , 2005 .
[62] W. Voos. Tom40: more than just a channel , 2003, Nature Structural Biology.
[63] R. Gillies,et al. Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.
[64] L. Alberghina,et al. Ras-dependent carbon metabolism and transformation in mouse fibroblasts , 2006, Oncogene.
[65] S. Tommasi,et al. OXIDATIVE PHOSPHORYLATION AND F0F1 ATP SYNTHASE ACTIVITY OF HUMAN HEPATOCELLULAR CARCINOMA , 1996 .
[66] J. Beechem,et al. Cell cycle dependent morphology changes and associated mitochondrial DNA redistribution in mitochondria of human cell lines. , 2002, Mitochondrion.
[67] Colin Adrain,et al. Role for CED-9 and Egl-1 as regulators of mitochondrial fission and fusion dynamics. , 2006, Molecular cell.
[68] I. Hall,et al. Variations in the subunit content and catalytic activity of the cytochrome c oxidase complex from different tissues and different cardiac compartments. , 1998, Biochimica et biophysica acta.
[69] L. Alberghina,et al. Characterization and Properties of Dominant-negative Mutants of the Ras-specific Guanine Nucleotide Exchange Factor CDC25Mm * , 1999, The Journal of Biological Chemistry.
[70] K. G. Hales. The machinery of mitochondrial fusion, division, and distribution, and emerging connections to apoptosis. , 2004, Mitochondrion.
[71] E. Eigenbrodt,et al. The tumor metabolome. , 2003, Anticancer research.
[72] P. Carmeliet,et al. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis , 1998, Nature.
[73] P. Bénit,et al. Succinate dehydrogenase deficiency in human , 2005, Cellular and Molecular Life Sciences CMLS.
[74] H. Krebs. The Pasteur effect and the relations between respiration and fermentation. , 1972, Essays in biochemistry.
[75] Kyu-Won Kim,et al. Hypoxia-inducible factor (HIF-1)α: its protein stability and biological functions , 2004, Experimental & Molecular Medicine.
[76] R. Gillies,et al. Microenvironmental and cellular consequences of altered blood flow in tumours. , 2003, The British journal of radiology.
[77] D. Largaespada,et al. Activation of the Rap1 Guanine Nucleotide Exchange Gene,CalDAG-GEF I, in BXH-2 Murine Myeloid Leukemia* , 2001, The Journal of Biological Chemistry.
[78] W. El-Deiry,et al. Overview of cell death signaling pathways , 2005, Cancer biology & therapy.
[79] S. Velasco-Miguel,et al. Mouse tumor model for neurofibromatosis type 1. , 1999, Science.
[80] A. Paradiso,et al. The role of pH dynamics and the Na+/H+ antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin--one single nature. , 2005, Biochimica et biophysica acta.
[81] Charis Eng,et al. A role for mitochondrial enzymes in inherited neoplasia and beyond , 2003, Nature Reviews Cancer.
[82] Qing‐Yu He,et al. Identification of tumor‐associated proteins in oral tongue squamous cell carcinoma by proteomics , 2004, Proteomics.
[83] W. Zwerschke,et al. Metabolic cooperation between different oncogenes during cell transformation: interaction between activated ras and HPV-16 E7 , 2001, Oncogene.
[84] J. Rojas,et al. H-Ras-specific activation of NF-κB protects NIH 3T3 cells against stimulus-dependent apoptosis , 2003, Oncogene.
[85] B. Chabi,et al. ANT2 Isoform Required for Cancer Cell Glycolysis , 2005, Journal of bioenergetics and biomembranes.
[86] M. Sheetz,et al. Mitochondrial Function and Actin Regulate Dynamin-Related Protein 1-Dependent Mitochondrial Fission , 2005, Current Biology.
[87] Yusuke Nakamura,et al. Identification of COX17 as a therapeutic target for non-small cell lung cancer. , 2003, Cancer research.
[88] M. Guppy,et al. Cancer metabolism: facts, fantasy, and fiction. , 2004, Biochemical and biophysical research communications.
[89] A. Reichert,et al. Genetic and structural characterization of the human mitochondrial inner membrane translocase. , 1999, Journal of molecular biology.
[90] P. Hollenbeck,et al. Nerve Growth Factor Signaling Regulates Motility and Docking of Axonal Mitochondria , 2004, Current Biology.
[91] J. Castro,et al. Suppression of oncogenic NRAS by RNA interference induces apoptosis of human melanoma cells , 2005, International journal of cancer.
[92] W. J. Brammar,et al. Differential expression of the mitochondrial gene cytochrome oxidase ii in benign and malignant breast tissue , 1992, The Journal of pathology.
[93] M. Ryan,et al. Functional analysis of human metaxin in mitochondrial protein import in cultured cells and its relationship with the Tom complex. , 2000, Biochemical and biophysical research communications.
[94] K. Ghoshal,et al. Mitochondrial Transcription Factor A and Its Downstream Targets Are Up-regulated in a Rat Hepatoma* , 2002, The Journal of Biological Chemistry.
[95] P. Kantoff,et al. Two differentially expressed genes in normal human prostate tissue and in carcinoma. , 1996, Cancer research.
[96] P. Carmeliet,et al. Role of HIF-1 alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis (vol 394, pg 485, 1998) , 1998 .
[97] L. Baggetto,et al. Deviant energetic metabolism of glycolytic cancer cells. , 1992, Biochimie.
[98] I. Leigh,et al. Fumarate hydratase mutations and predisposition to cutaneous leiomyomas, uterine leiomyomas and renal cancer , 2005, The British journal of dermatology.
[99] William C Hahn,et al. Rules for making human tumor cells. , 2002, The New England journal of medicine.
[100] Robert S. Balaban,et al. Mitochondria, Oxidants, and Aging , 2005, Cell.
[101] Kathy Pfeiffer,et al. Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma. , 2002, Carcinogenesis.
[102] S. Kornbluth,et al. Mitochondria at the Crossroad of Apoptotic Cell Death , 1999, Journal of bioenergetics and biomembranes.
[103] M. Takeda,et al. ASC1/RAS2 Suppresses the Growth Defect on Glycerol Caused by the atp1–2 Mutation in the YeastSaccharomyces cerevisiae * , 2000, The Journal of Biological Chemistry.
[104] M. Bauer,et al. Mitochondrial Function and Biogenesis , 2004, Topics in Current Genetics.
[105] Keshav K. Singh. Mitochondria damage checkpoint in apoptosis and genome stability. , 2004, FEMS yeast research.
[106] E. Domany,et al. Nanog transforms NIH3T3 cells and targets cell-type restricted genes. , 2006, Biochemical and biophysical research communications.
[107] C. Otto,et al. Adaptive changes in the expression of nuclear and mitochondrial encoded subunits of cytochrome c oxidase and the catalytic activity during hypoxia. , 2003, European journal of biochemistry.
[108] K. Webster,et al. Hypoxia Regulates β-Enolase and Pyruvate Kinase-M Promoters by Modulating Sp1/Sp3 Binding to a Conserved GC Element* , 1998, The Journal of Biological Chemistry.
[109] Bernhard Wolf,et al. Relevance of tumor microenvironment for progression, therapy and drug development. , 2004, Anti-cancer drugs.
[110] K. Mihara,et al. Regulation of mitochondrial morphology through proteolytic cleavage of OPA1 , 2006, The EMBO journal.
[111] L. Alberghina,et al. Systems Biology: Definitions and Perspectives , 2005 .
[112] B. Chernyak,et al. Oligomycin, inhibitor of the F0 part of H+-ATP-synthase, suppresses the TNF-induced apoptosis , 2002, Oncogene.
[113] T. Nyström,et al. Ras proteins control mitochondrial biogenesis and function inSaccharomyces cerevisiae , 2008, Folia Microbiologica.
[114] W. Sivitz,et al. Effects of Adenoviral Overexpression of Uncoupling Protein-2 and -3 on Mitochondrial Respiration in Insulinoma Cells* * This work was supported by V.A. Medical Research Funds and NIH Grants DK-25295 and HD-29569. , 2001, Endocrinology.
[115] H. Fritsche,et al. Calcium-induced activation of a mutant G-protein-coupled receptor causes in vitro transformation of NIH/3T3 cells. , 1999, Neoplasia.
[116] P. Schrauwen,et al. The role of uncoupling protein 3 in fatty acid metabolism: protection against lipotoxicity? , 2004, The Proceedings of the Nutrition Society.
[117] T. Lithgow,et al. Tom40, the import channel of the mitochondrial outer membrane, plays an active role in sorting imported proteins , 2003, The EMBO journal.
[118] John Calvin Reed,et al. The Mitochondrial F0F1-ATPase proton pump is required for function of the proapoptotic protein Bax in yeast and mammalian cells. , 1998, Molecular cell.
[119] Mukesh Verma,et al. Proteomic analysis of cancer-cell mitochondria , 2003, Nature Reviews Cancer.
[120] C. Dang,et al. Deregulation of Glucose Transporter 1 and Glycolytic Gene Expression by c-Myc* , 2000, The Journal of Biological Chemistry.
[121] David G. Watson,et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. , 2005, Cancer cell.
[122] J. Auwerx,et al. PGC-1alpha: turbocharging mitochondria. , 2004, Cell.
[123] M. Hüttemann,et al. Mitochondrial energy metabolism is regulated via nuclear-coded subunits of cytochrome c oxidase. , 2000, Free radical biology & medicine.
[124] L. Alberghina,et al. A dominant negative RAS-specific guanine nucleotide exchange factor reverses neoplastic phenotype in K-ras transformed mouse fibroblasts , 2000, Oncogene.
[125] N. Sang,et al. Hypoxia-inducible Factor-1-mediated Expression of the 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) Gene , 2002, The Journal of Biological Chemistry.
[126] David Beach,et al. Glycolytic enzymes can modulate cellular life span. , 2005, Cancer research.
[127] Edward M. Johnson,et al. Ras‐induced colony formation and anchorage‐independent growth inhibited by elevated expression of Purα in NIH3T3 cells , 2001, Journal of cellular biochemistry.
[128] N. Amariglio,et al. Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor-1alpha, causing glycolysis shutdown and cell death. , 2005, Cancer research.
[129] N. Hamasaki,et al. Mitochondrial Transcription Factor A in the Maintenance of Mitochondrial DNA , 2005, Annals of the New York Academy of Sciences.
[130] E. Winter,et al. The c-K-ras gene and human cancer (review). , 1987, Anticancer research.
[131] J. Gray,et al. Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer , 2002, Nature Genetics.
[132] Channing J Der,et al. The dark side of Ras: regulation of apoptosis , 2003, Oncogene.
[133] R. Barbour,et al. Adenine nucleotide transport in hepatoma mitochondria. Characterization of factors influencing the kinetics of ADP and ATP uptake. , 1983, Biochimica et biophysica acta.
[134] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[135] R. Barbour,et al. Adenine nucleotide transport in hepatoma mitochondria and its correlation with hepatoma growth rates and tumor size. , 1983, Cancer research.
[136] John A. Hall,et al. mtDNA mutations increase tumorigenicity in prostate cancer. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[137] D. Chaplin,et al. Microenvironmental control of gene expression: implications for tumor angiogenesis, progression, and metastasis. , 1998, Seminars in radiation oncology.
[138] Keshav K. Singh. Mitochondrial Dysfunction Is a Common Phenotype in Aging and Cancer , 2004, Annals of the New York Academy of Sciences.
[139] Saroj P. Mathupala,et al. Aberrant Glycolytic Metabolism of Cancer Cells: A Remarkable Coordination of Genetic, Transcriptional, Post-translational, and Mutational Events That Lead to a Critical Role for Type II Hexokinase , 1997, Journal of bioenergetics and biomembranes.
[140] Saroj P. Mathupala,et al. Glucose Catabolism in Cancer Cells , 2001, The Journal of Biological Chemistry.
[141] G. Semenza,et al. Oncogenic alterations of metabolism. , 1999, Trends in biochemical sciences.
[142] Icksoo Lee,et al. The possible role of cytochrome c oxidase in stress-induced apoptosis and degenerative diseases. , 2004, Biochimica et biophysica acta.
[143] J. Marín-García,et al. Mitochondrial signaling pathways: A receiver/integrator organelle , 2004, Molecular and Cellular Biochemistry.
[144] A. Bonen,et al. Constitutive UCP3 overexpression at physiological levels increases mouse skeletal muscle capacity for fatty acid transport and oxidation , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[145] M. Rigoulet,et al. The yeast cAMP protein kinase Tpk3p is involved in the regulation of mitochondrial enzymatic content during growth. , 2005, Biochimica et biophysica acta.
[146] P. Hollenbeck. The pattern and mechanism of mitochondrial transport in axons. , 1996, Frontiers in bioscience : a journal and virtual library.
[147] P. Pippia,et al. Static cytofluorometry and fluorescence morphology of mitochondria and DNA in proliferating fibroblasts. , 1996, Biotechnic & histochemistry : official publication of the Biological Stain Commission.